The Rheumatologist
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
  • Technology
    • Electronic Health Records
    • Apps
    • Information Technology
  • Resources
    • Issue Archives
    • Events
    • Multimedia
      • Audio
      • Video
    • From the College
    • American College of Rheumatology
    • Rheumatology Research Foundation
    • Arthritis & Rheumatology
    • Arthritis Care & Research
    • Treatment Guidelines
    • Research Reviews
    • Annual Meeting
      • Abstracts
      • Meeting Reports
    • Rheumatology Image Bank
    • ACR ExamRheum
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Senate Democrats Introduce Bill to Allow Government to Block Drug Price Rises

Senate Democrats Introduce Bill to Allow Government to Block Drug Price Rises

December 14, 2018 • By Reuters Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

WASHINGTON (Reuters)—Four Democratic U.S. senators introduced a bill on Thursday that would allow the government to block drug price increases that it decides are unjustified.

You Might Also Like
  • Sen. Sanders, Rep. Cummings to Introduce Bill to Lower U.S. Drug Prices
  • U.S. House Democrats Introduce Sweeping Medicare for All Bill
  • U.S. Democrats Seek Trump’s Cooperation on Drug Price Reform

The bill sponsored by Senators Richard Blumenthal, Kamala Harris, Amy Klobuchar and Jeff Merkley, all Democrats, would allow the Department of Health and Human Services to prohibit drug price increases that it deems excessive.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Both Republicans and Democrats have put the issue of fast-rising drug prices – some for drugs like insulin that have been on the market for decades – on their agenda.

Representative Nancy Pelosi, who leads Democrats in the House of Representatives, has pledged to pursue an agenda next year that includes tackling the issue of high and rising prescription drug prices.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

U.S. President Donald Trump has blasted drugmakers and healthcare “middlemen” for making prescription medicines unaffordable for Americans.

Filed Under: Legislation & Advocacy Tagged With: drug price legislation, Jeff Merkley, Kamala Harris, prohibit drug price increases, Richard Blumenthal, Sen. Amy Klobuchar

You Might Also Like:
  • Sen. Sanders, Rep. Cummings to Introduce Bill to Lower U.S. Drug Prices
  • U.S. House Democrats Introduce Sweeping Medicare for All Bill
  • U.S. Democrats Seek Trump’s Cooperation on Drug Price Reform
  • Maryland Lawmakers Approve Bill to Fight Drug Price-Gouging

ACR/ARP Annual Meeting

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Annual Meeting site »

ACR/ARP Meeting Abstracts

Browse and search abstracts from the ACR/ARP Annual Meetings going back to 2012.

Visit the ACR/ARP Meeting Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2019 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.